Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine

William Raymond Herzog, Paul A. Gurbel, Robert A. Vogel, Matthew L. Schlossberg, Alan I. Schneider, Victor L. Serebruany

Research output: Contribution to journalArticle

Abstract

Background: NPC is a member of the leumedins and is an inhibitor of leukocyte adhesion to endothelium via blockage of integrin binding. NPC 15669 also may have anti-platelet effects. We tested the efficacy of the novel leukocyte recruitment inhibitor NPC 15669 on myocardial stunning (MS) and preconditioned myocardial infarction (MI). Methods and Results: In an open-chested swine model, NPC 15669 (10 mg NPC/kg loading dose followed by constant infusion at 6 mg/kg/hr) was administered in six animals. Myocardial thickening (MT) was determined by epicardial ultrasound. The left anterior descending artery was occluded for 8 minutes followed by 90 minutes of reperfusion, during which myocardial MT was recorded at regular intervals. We have found that treatment with NPC 15669 increases myocardial contractility and significantly decreases MS time compared to controls (26.7±4.0 minutes vs. 50.0±4.3 minutes, p=.0026). In NPC 15669-treated animals we observed a reduction of MI size (23.4±6.7% of tissue at risk became necrotic compared to 53.0±6.6% in controls, p=.0102). Conclusions: Our data suggest that NPC 15669 significantly reduces myocardial injury in both the stunning and infarction models.

Original languageEnglish (US)
Pages (from-to)163-170
Number of pages8
JournalJournal of Thrombosis and Thrombolysis
Volume1
Issue number2
DOIs
StatePublished - Jun 1995
Externally publishedYes

Fingerprint

Myocardial Stunning
Infarction
Swine
Leukocytes
Myocardial Infarction
Integrins
Reperfusion
Endothelium
N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine
Thorax
Blood Platelets
Arteries
Wounds and Injuries

Keywords

  • animal model
  • myocardial infarction
  • myocardial stunning
  • NPC 15669

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Herzog, W. R., Gurbel, P. A., Vogel, R. A., Schlossberg, M. L., Schneider, A. I., & Serebruany, V. L. (1995). Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine. Journal of Thrombosis and Thrombolysis, 1(2), 163-170. https://doi.org/10.1007/BF01062574

Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine. / Herzog, William Raymond; Gurbel, Paul A.; Vogel, Robert A.; Schlossberg, Matthew L.; Schneider, Alan I.; Serebruany, Victor L.

In: Journal of Thrombosis and Thrombolysis, Vol. 1, No. 2, 06.1995, p. 163-170.

Research output: Contribution to journalArticle

Herzog, WR, Gurbel, PA, Vogel, RA, Schlossberg, ML, Schneider, AI & Serebruany, VL 1995, 'Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine', Journal of Thrombosis and Thrombolysis, vol. 1, no. 2, pp. 163-170. https://doi.org/10.1007/BF01062574
Herzog, William Raymond ; Gurbel, Paul A. ; Vogel, Robert A. ; Schlossberg, Matthew L. ; Schneider, Alan I. ; Serebruany, Victor L. / Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine. In: Journal of Thrombosis and Thrombolysis. 1995 ; Vol. 1, No. 2. pp. 163-170.
@article{3788d5312ed84a68a6fa9d21577b31b3,
title = "Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine",
abstract = "Background: NPC is a member of the leumedins and is an inhibitor of leukocyte adhesion to endothelium via blockage of integrin binding. NPC 15669 also may have anti-platelet effects. We tested the efficacy of the novel leukocyte recruitment inhibitor NPC 15669 on myocardial stunning (MS) and preconditioned myocardial infarction (MI). Methods and Results: In an open-chested swine model, NPC 15669 (10 mg NPC/kg loading dose followed by constant infusion at 6 mg/kg/hr) was administered in six animals. Myocardial thickening (MT) was determined by epicardial ultrasound. The left anterior descending artery was occluded for 8 minutes followed by 90 minutes of reperfusion, during which myocardial MT was recorded at regular intervals. We have found that treatment with NPC 15669 increases myocardial contractility and significantly decreases MS time compared to controls (26.7±4.0 minutes vs. 50.0±4.3 minutes, p=.0026). In NPC 15669-treated animals we observed a reduction of MI size (23.4±6.7{\%} of tissue at risk became necrotic compared to 53.0±6.6{\%} in controls, p=.0102). Conclusions: Our data suggest that NPC 15669 significantly reduces myocardial injury in both the stunning and infarction models.",
keywords = "animal model, myocardial infarction, myocardial stunning, NPC 15669",
author = "Herzog, {William Raymond} and Gurbel, {Paul A.} and Vogel, {Robert A.} and Schlossberg, {Matthew L.} and Schneider, {Alan I.} and Serebruany, {Victor L.}",
year = "1995",
month = "6",
doi = "10.1007/BF01062574",
language = "English (US)",
volume = "1",
pages = "163--170",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Effects of a novel leumedin NPC 15669 on myocardial stunning and preconditioned infarction size in swine

AU - Herzog, William Raymond

AU - Gurbel, Paul A.

AU - Vogel, Robert A.

AU - Schlossberg, Matthew L.

AU - Schneider, Alan I.

AU - Serebruany, Victor L.

PY - 1995/6

Y1 - 1995/6

N2 - Background: NPC is a member of the leumedins and is an inhibitor of leukocyte adhesion to endothelium via blockage of integrin binding. NPC 15669 also may have anti-platelet effects. We tested the efficacy of the novel leukocyte recruitment inhibitor NPC 15669 on myocardial stunning (MS) and preconditioned myocardial infarction (MI). Methods and Results: In an open-chested swine model, NPC 15669 (10 mg NPC/kg loading dose followed by constant infusion at 6 mg/kg/hr) was administered in six animals. Myocardial thickening (MT) was determined by epicardial ultrasound. The left anterior descending artery was occluded for 8 minutes followed by 90 minutes of reperfusion, during which myocardial MT was recorded at regular intervals. We have found that treatment with NPC 15669 increases myocardial contractility and significantly decreases MS time compared to controls (26.7±4.0 minutes vs. 50.0±4.3 minutes, p=.0026). In NPC 15669-treated animals we observed a reduction of MI size (23.4±6.7% of tissue at risk became necrotic compared to 53.0±6.6% in controls, p=.0102). Conclusions: Our data suggest that NPC 15669 significantly reduces myocardial injury in both the stunning and infarction models.

AB - Background: NPC is a member of the leumedins and is an inhibitor of leukocyte adhesion to endothelium via blockage of integrin binding. NPC 15669 also may have anti-platelet effects. We tested the efficacy of the novel leukocyte recruitment inhibitor NPC 15669 on myocardial stunning (MS) and preconditioned myocardial infarction (MI). Methods and Results: In an open-chested swine model, NPC 15669 (10 mg NPC/kg loading dose followed by constant infusion at 6 mg/kg/hr) was administered in six animals. Myocardial thickening (MT) was determined by epicardial ultrasound. The left anterior descending artery was occluded for 8 minutes followed by 90 minutes of reperfusion, during which myocardial MT was recorded at regular intervals. We have found that treatment with NPC 15669 increases myocardial contractility and significantly decreases MS time compared to controls (26.7±4.0 minutes vs. 50.0±4.3 minutes, p=.0026). In NPC 15669-treated animals we observed a reduction of MI size (23.4±6.7% of tissue at risk became necrotic compared to 53.0±6.6% in controls, p=.0102). Conclusions: Our data suggest that NPC 15669 significantly reduces myocardial injury in both the stunning and infarction models.

KW - animal model

KW - myocardial infarction

KW - myocardial stunning

KW - NPC 15669

UR - http://www.scopus.com/inward/record.url?scp=0000096817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000096817&partnerID=8YFLogxK

U2 - 10.1007/BF01062574

DO - 10.1007/BF01062574

M3 - Article

AN - SCOPUS:0000096817

VL - 1

SP - 163

EP - 170

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 2

ER -